Erratum: Future of pediatric therapeutics: Reauthorization of BPCA and PREA (Clinical Pharmacology and Therapeutics (2007) 81, (477-479) DOI: 10.1038/sj.clpt.6100109);Future of pediatric therapeutics: Reauthorization of BPCA and PREA

Clinical Pharmacology and Therapeutics

Volumn 81, Issue 4, 2007, Pages 477-479

  Ward, R M ^a   Kauffman, R ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; FLUVOXAMINE; GABAPENTIN; ONDANSETRON; THALIDOMIDE;

BEHAVIOR DISORDER; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; DRUG USE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; INFORMATION PROCESSING; LAW; MEDICAL ETHICS; MEDICAL LIABILITY; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PHOCOMELIA; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 33947355479     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100244     Document Type: Erratum

References (1)

1. American Association of Physicians, Committee on Clinical Research Involving Children, Board on Health Sciences Policy. Ethical Conduct of Research Involving Children. Field, M.J. & Behrman, R.E., eds.. (National Academies Press, Washington, DC, 2004).